WASHINGTON, D.C. – (January 31, 2024) – Following the release of the proposed 2025 Medicare Advantage (MA) and Part D Advance Notice from the Centers for Medicare & Medicaid Services (CMS), AHIP President and CEO Mike Tuffin issued the following statement:
“We are carefully reviewing this complex set of proposals which will impact coverage and care for the more than 50 million beneficiaries who rely on Medicare Advantage and Part D.
“We know that in the post-pandemic environment, MA plans are supporting seniors as they access deferred care and resume normal utilization of medical services at a time of rising medical costs. As significant reforms to Part D are implemented and drug costs continue to rise, it is also critical to ensure enrollees continue to have stable access to high-quality, affordable drug coverage.
“Medicare Advantage is the preferred coverage option for more than half of eligible Medicare beneficiaries because it provides them better care at lower costs. In addition, more than 23 million seniors and individuals with disabilities have chosen to enroll in stand-alone Part D plans for affordable access to the prescription drugs they need.”